171 related articles for article (PubMed ID: 24144409)
1. Identification of novel benzimidazole derivatives as anti-Trypanosoma cruzi agents: solid-phase synthesis, structure-activity relationships and molecular docking studies.
Ríos N; Varela J; Birriel E; González M; Cerecetto H; Merlino A; Porcal W
Future Med Chem; 2013 Oct; 5(15):1719-32. PubMed ID: 24144409
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and biological evaluation of 2-methyl-1H-benzimidazole-5-carbohydrazides derivatives as modifiers of redox homeostasis of Trypanosoma cruzi.
Melchor-Doncel de la Torre S; Vázquez C; González-Chávez Z; Yépez-Mulia L; Nieto-Meneses R; Jasso-Chávez R; Saavedra E; Hernández-Luis F
Bioorg Med Chem Lett; 2017 Aug; 27(15):3403-3407. PubMed ID: 28648464
[TBL] [Abstract][Full Text] [Related]
3. Molecular modeling and structure-activity relationships for a series of benzimidazole derivatives as cruzain inhibitors.
Pauli I; Ferreira LG; de Souza ML; Oliva G; Ferreira RS; Dessoy MA; Slafer BW; Dias LC; Andricopulo AD
Future Med Chem; 2017 May; 9(7):641-657. PubMed ID: 28509592
[TBL] [Abstract][Full Text] [Related]
4. New benzimidazolequinones as trypanosomicidal agents.
López-Lira C; Tapia RA; Herrera A; Lapier M; Maya JD; Soto-Delgado J; Oliver AG; Graham Lappin A; Uriarte E
Bioorg Chem; 2021 Jun; 111():104823. PubMed ID: 33798844
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, Biological Evaluation and Molecular Docking of New Benzenesulfonylhydrazone as Potential anti-Trypanosoma cruzi Agents.
Elizondo-Jimenez S; Moreno-Herrera A; Reyes-Olivares R; Dorantes-Gonzalez E; Nogueda-Torres B; Oliveira EAG; Romeiro NC; Lima LM; Palos I; Rivera G
Med Chem; 2017; 13(2):149-158. PubMed ID: 27396731
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis and molecular docking studies of novel N-arylsulfonyl-benzimidazoles with anti Trypanosoma cruzi activity.
Miana GE; Ribone SR; Vera DMA; Sánchez-Moreno M; Mazzieri MR; Quevedo MA
Eur J Med Chem; 2019 Mar; 165():1-10. PubMed ID: 30641409
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis and cruzain docking of 3-(4-substituted-aryl)-1,2,4-oxadiazole-N-acylhydrazones as anti-Trypanosoma cruzi agents.
dos Santos Filho JM; Leite AC; de Oliveira BG; Moreira DR; Lima MS; Soares MB; Leite LF
Bioorg Med Chem; 2009 Sep; 17(18):6682-91. PubMed ID: 19683450
[TBL] [Abstract][Full Text] [Related]
8. Structural design, synthesis and pharmacological evaluation of thiazoles against Trypanosoma cruzi.
de Oliveira Filho GB; Cardoso MVO; Espíndola JWP; Oliveira E Silva DA; Ferreira RS; Coelho PL; Anjos PSD; Santos ES; Meira CS; Moreira DRM; Soares MBP; Leite ACL
Eur J Med Chem; 2017 Dec; 141():346-361. PubMed ID: 29031078
[TBL] [Abstract][Full Text] [Related]
9. Synthesis of New Thiosemicarbazones and Semicarbazones Containing the 1,2,3-1H-triazole-isatin Scaffold: Trypanocidal, Cytotoxicity, Electrochemical Assays, and Molecular Docking.
Silva BNM; Sales Junior PA; Romanha AJ; Murta SMF; Lima CHS; Albuquerque MG; D'Elia E; Rodrigues JGA; Ferreira VF; Silva FC; Pinto AC; Silva BV
Med Chem; 2019; 15(3):240-256. PubMed ID: 30332972
[TBL] [Abstract][Full Text] [Related]
10. Structural design, synthesis and structure-activity relationships of thiazolidinones with enhanced anti-Trypanosoma cruzi activity.
Moreira DR; Leite AC; Cardoso MV; Srivastava RM; Hernandes MZ; Rabello MM; da Cruz LF; Ferreira RS; de Simone CA; Meira CS; Guimaraes ET; da Silva AC; dos Santos TA; Pereira VR; Soares MB
ChemMedChem; 2014 Jan; 9(1):177-88. PubMed ID: 24203393
[TBL] [Abstract][Full Text] [Related]
11. New 1,3-thiazole derivatives and their biological and ultrastructural effects on Trypanosoma cruzi.
de Moraes Gomes PAT; de Oliveira Barbosa M; Farias Santiago E; de Oliveira Cardoso MV; Capistrano Costa NT; Hernandes MZ; Moreira DRM; da Silva AC; Dos Santos TAR; Pereira VRA; Brayner Dos Santosd FA; do Nascimento Pereira GA; Ferreira RS; Leite ACL
Eur J Med Chem; 2016 Oct; 121():387-398. PubMed ID: 27295485
[TBL] [Abstract][Full Text] [Related]
12. Assessment of the Activity of Nitroisoxazole Derivatives against
Moncada-Basualto M; Saavedra-Olavarría J; Rivero-Jerez PS; Rojas C; Maya JD; Liempi A; Zúñiga-Bustos M; Olea-Azar C; Lapier M; Pérez EG; Pozo-Martínez J
Molecules; 2024 Jun; 29(12):. PubMed ID: 38930828
[TBL] [Abstract][Full Text] [Related]
13. 5-Nitro-2-furfuriliden derivatives as potential anti-Trypanosoma cruzi agents: design, synthesis, bioactivity evaluation, cytotoxicity and exploratory data analysis.
Palace-Berl F; Jorge SD; Pasqualoto KF; Ferreira AK; Maria DA; Zorzi RR; de Sá Bortolozzo L; Lindoso JÂ; Tavares LC
Bioorg Med Chem; 2013 Sep; 21(17):5395-406. PubMed ID: 23816040
[TBL] [Abstract][Full Text] [Related]
14. Second generation of 2H-benzimidazole 1,3-dioxide derivatives as anti-trypanosomatid agents: synthesis, biological evaluation, and mode of action studies.
Boiani M; Boiani L; Merlino A; Hernández P; Chidichimo A; Cazzulo JJ; Cerecetto H; González M
Eur J Med Chem; 2009 Nov; 44(11):4426-33. PubMed ID: 19616875
[TBL] [Abstract][Full Text] [Related]
15. 2H-benzimidazole 1,3-dioxide derivatives: a new family of water-soluble anti-trypanosomatid agents.
Boiani M; Boiani L; Denicola A; Torres de Ortiz S; Serna E; Vera de Bilbao N; Sanabria L; Yaluff G; Nakayama H; Rojas de Arias A; Vega C; Rolan M; Gómez-Barrio A; Cerecetto H; Gonzalez M
J Med Chem; 2006 Jun; 49(11):3215-24. PubMed ID: 16722639
[TBL] [Abstract][Full Text] [Related]
16. Determination and characterization of new benzimidazoles with activity against Trypanosoma cruzi by UV spectroscopy and HPLC.
Brain-Isasi S; Quezada C; Pessoa H; Morello A; Kogan MJ; Alvarez-Lueje A
Bioorg Med Chem; 2008 Aug; 16(16):7622-30. PubMed ID: 18657978
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis, molecular docking and biological evaluation of thiophen-2-iminothiazolidine derivatives for use against Trypanosoma cruzi.
Silva-Júnior EF; Silva EPS; França PHB; Silva JPN; Barreto EO; Silva EB; Ferreira RS; Gatto CC; Moreira DRM; Siqueira-Neto JL; Mendonça-Júnior FJB; Lima MCA; Bortoluzzi JH; Scotti MT; Scotti L; Meneghetti MR; Aquino TM; Araújo-Júnior JX
Bioorg Med Chem; 2016 Sep; 24(18):4228-4240. PubMed ID: 27475533
[TBL] [Abstract][Full Text] [Related]
18. 2-Pyridyl thiazoles as novel anti-Trypanosoma cruzi agents: structural design, synthesis and pharmacological evaluation.
Cardoso MV; de Siqueira LR; da Silva EB; Costa LB; Hernandes MZ; Rabello MM; Ferreira RS; da Cruz LF; Moreira DR; Pereira VR; de Castro MC; Bernhardt PV; Leite AC
Eur J Med Chem; 2014 Oct; 86():48-59. PubMed ID: 25147146
[TBL] [Abstract][Full Text] [Related]
19. Novel drug design for Chagas disease via targeting Trypanosoma cruzi tubulin: Homology modeling and binding pocket prediction on Trypanosoma cruzi tubulin polymerization inhibition by naphthoquinone derivatives.
Ogindo CO; Khraiwesh MH; George M; Brandy Y; Brandy N; Gugssa A; Ashraf M; Abbas M; Southerland WM; Lee CM; Bakare O; Fang Y
Bioorg Med Chem; 2016 Aug; 24(16):3849-55. PubMed ID: 27345756
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis, and biological evaluation of new growth inhibitors of Trypanosoma cruzi (epimastigotes).
Schvartzapel AJ; Zhong L; Docampo R; Rodriguez JB; Gros EG
J Med Chem; 1997 Jul; 40(15):2314-22. PubMed ID: 9240347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
